MOMETASONE FUROATE | N020762 | ORGANON LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc. 1 patentANDA 205149mometasone furoate | D. Del. | 2014-07-03 | Terminated 2016-11-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Aurobindo Pharma USA Inc FDA-2022-P-0077 Aurobindo Pharma USA Inc filed this citizen petition on January 14, 2022, requesting that the FDA determine whether NASONEX (mometasone furoate monohydrate) Nasal Spray 0.05 mg/spray under NDA 020762 held by Organon LLC was voluntarily withdrawn from sale for safety or effectiveness reasons, citing | 505(q) | 2022-01-18 | Withdrawn | Aurobindo Pharma USA Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.